Cetera Advisor Networks’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Cetera Advisor Networks’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,762	Closed	-$15.7K	–	2702
2022 Q4	$15.7K	Sell	17,762 -7,118	-29%	-$9.44K	﹤0.01%	2494
2022 Q3	$39K	Buy	24,880 +2,425	+11%	+$5.5K	﹤0.01%	2028
2022 Q2	$45K	Buy	22,455 +3,800	+20%	+$6.57K	﹤0.01%	2008
2022 Q1	$43K	Buy	18,655 +1,000	+6%	+$3.12K	﹤0.01%	2023
2021 Q4	$82K	Buy	+17,655	New	+$110K	﹤0.01%	1979
2020 Q3	–	Sell	-8,250	Closed	-$52K	–	3233
2020 Q2	$52K	Buy	+8,250	New	+$31.6K	﹤0.01%	1875

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return